Hans Vitzthum | Investor Relations |
Raj Kannan | Chief Executive Officer |
Peter Lang | Chief Financial Officer |
Gary Sternberg | Chief Medical Officer |
Michelle Senchyna | Head-Clinical Development and Operations |
Casey Kopczynski | Co-Founder, Head-Research and External Innovation |
Serge Belanger | Needham |
Annabel Samimy | Stifel |
Stacy Ku | Cowen |
Greg Fraser | Truist |
Good afternoon. Thank you for standing by, and welcome to the Aerie Pharmaceuticals Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. Today's conference will be recorded.